Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from Incyte Corporation.

Advances in™: Biomarkers and Targeted Treatment Approaches for Gastrointestinal Cancers

Release Date: March 17, 2020
Expiration Date: March 17, 2021
Media: Internet - based

Activity Overview

This online educational activity is designed to provide expert interpretation of new and emerging data on biomarkers used to guide treatment decisions for gastrointestinal (GI) cancers, with a forward-looking perspective on how novel biomarkers might impact clinical practice. This overview on how current biomarkers are integrated into GI cancer treatment decisions, as well as novel biomarkers that may lead to paradigm treatment shifts, will be presented in a multimedia format, including a series of video interviews with an expert thought leader integrated into text-based elements.

Acknowledgement of Commercial Support

This activity is supported by an educational grant from Incyte Corporation.

Instructions for This Activity and Receiving Credit

  • You will need to log in to participate in the activity.
  • Each presentation may contain an interactive question(s). You may move forward through the presentation; however, you may not go back to change answers or review video/content until you finish the presentation.
  • At the end of the activity, “Educational Content/Video” will be available for your reference.
  • In order to receive a CME Certificate, you must complete the activity.
  • Complete the Posttest and Evaluation, and then click on “Request for Credit.” You may immediately download a CME Certificate upon completion of these steps.

Target Audience

This educational initiative is directed toward medical oncologists, surgical oncologists, pathologists, radiation oncologists, and gastroenterologists who treat patients with GI cancers. Nurse practitioners, physician assistants, nurses, and other healthcare professionals involved in the treatment and management of patients with GI cancers are also invited to participate.

Learning Objectives

Upon successful completion of this educational activity, you should be better prepared to:

  • Identify actionable biomarkers in GI cancers that can guide therapeutic decision-making
  • Outline current and emerging testing strategies to test for mismatch repair deficiency/microsatellite instability and other actionable biomarkers in GI cancers
  • Evaluate recent clinical trial data regarding biomarker-guided therapeutic strategies in the treatment of GI cancers
  • Formulate a plan of care to monitor for and mitigate adverse events associated with emerging biomarker-guided therapeutic options in GI cancers

Faculty, Staff, and Planners’ Disclosures


Ryan B. Corcoran
Ryan B. Corcoran, MD, PhD
Director, GI Cancer Center Program
Scientific Director, Termeer Center for Targeted Therapy
Massachusetts General Hospital Cancer Center
Associate Professor of Medicine
Harvard Medical School
Boston, MA

Disclosures: Grant/Research Support: Asana, AstraZeneca, Eli Lilly; Consultant: Array, Avidity Biosciences, Bristol-Myers Squibb, C4 Therapeutics, Elicio, Kinnate Biopharma, Guardant Health, Ipsen, Natera, N-of-One, nRichDX, Revolution Medicines, Shionogi, Taiho Oncology, Zikani; Stock/Shareholder: Avidity Biosciences, C4 Therapeutics, Revolution Medicines, nRichDX, Kinnate Biopharma.

The staff of Physicians' Education Resource®, LLC (PER®) have no relevant financial relationships with commercial interests to disclose.

Disclosure Policy and Resolution of Conflicts of Interest (COI)

As a sponsor accredited by the ACCME, it is the policy of PER® to ensure fair balance, independence, objectivity, and scientific rigor in all of its CME activities. In compliance with ACCME guidelines, PER® requires everyone who is in a position to control the content of a CME activity to disclose all relevant financial relationships with commercial interests. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that creates a COI.

Additionally, PER® is required by ACCME to resolve all COI. PER® has identified and resolved all COI prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This CME activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing medical education purposes only and is not meant to substitute for the independent clinical judgment of a physician relative to diagnostic or treatment options for a specific patient’s medical condition.

The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or the company that provided commercial support.

Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
Filter By